Fmoc-2,6-dimethyl-L-tyrosine is an amino acid derivative used in peptide synthesis. It is a protected form of tyrosine that is used to create peptide sequences, and it is commonly used in medicinal chemistry and biochemistry.
CAT No: 10-101-235
CAS No:206060-54-0
Synonyms/Alias:206060-54-0;Fmoc-2,6-dimethyl-L-tyrosine;(S)-N-Fmoc-2,6-Dimethyltyrosine;fmoc-l-(2,6-di-me)tyr-oh;L-Tyrosine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2,6-dimethyl-;(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(4-hydroxy-2,6-dimethylphenyl)propanoic acid;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-hydroxy-2,6-dimethylphenyl)propanoic acid;N-[(9H-fluoren-9-ylmethoxy)carbonyl]-2,6-dimethyl-L-Tyrosine;MFCD01632251;Fmoc-L-2,6-Dimethyltyrosine;SCHEMBL1556702;DTXSID80610808;N-Fmoc-2,6-dimethyl-L-tyrosine;RHSSAHKTHNKPGU-DEOSSOPVSA-N;AKOS015837103;AKOS015901755;MG-0722;(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-(4-hydroxy-2,6-dimethylphenyl)propanoic acid;2,6-Dimethyl-L-tyrosine, N-Fmoc protected;DB-001155;CS-0101061;(S)-N-alpha-(9-Fluorenylmethyloxycarbonyl)-2,6-dimethyl-tyrosine;N-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-2,6-dimethyl-L-tyrosine;(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(4-hydroxy-2,6-dimethylphenyl)propanoic acid;(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-hydroxy-2,6-dimethylphenyl)propanoicacid;(S)-2-(((9H-FLUOREN-9-YL)METHOXY)CARBONYLAMINO)-3-(4-HYDROXY-2,6-DIMETHYLPHENYL)PROPANOIC ACID;
Fmoc-2,6-dimethyl-L-tyrosine is a synthetic amino acid derivative featuring an Fmoc (9-fluorenylmethyloxycarbonyl) protecting group and methyl substitutions at the 2 and 6 positions of the tyrosine aromatic ring. This compound is primarily utilized in the field of peptide chemistry, where its unique structural modifications confer distinct steric and electronic properties. The presence of the Fmoc group enables efficient incorporation of the residue into peptide chains using solid-phase peptide synthesis (SPPS) methodologies. The dimethyl substitutions on the tyrosine side chain alter its reactivity and conformational preferences, making this building block valuable for designing peptides with tailored physicochemical characteristics or enhanced biological stability.
Peptide Synthesis: Fmoc-2,6-dimethyl-L-tyrosine is widely employed as a protected amino acid building block in SPPS protocols. Its Fmoc protection facilitates selective deprotection under mild basic conditions, allowing for stepwise elongation of peptide chains with high fidelity. The methyl substitutions on the aromatic ring can reduce undesired side reactions such as oxidation or aggregation during synthesis, thereby improving the overall yield and purity of complex peptides. Researchers use this compound to introduce steric bulk and hydrophobicity at specific positions within peptide sequences, enabling the exploration of structure-activity relationships and the development of peptides with improved performance in biochemical assays.
Peptide Engineering: The incorporation of 2,6-dimethyl-L-tyrosine into peptide backbones is a strategic approach for modulating conformational rigidity and side-chain interactions. The steric hindrance generated by the methyl groups can restrict the rotational freedom of the aromatic ring, influencing the secondary structure and folding patterns of the resulting peptides. This property is particularly valuable for the design of peptidomimetics, constrained peptides, and analogues intended to mimic or disrupt protein-protein interactions. By leveraging the unique characteristics of this residue, researchers can fine-tune the biophysical properties and stability of synthetic peptides for advanced research applications.
Structure-Activity Relationship Studies: The use of Fmoc-2,6-dimethyl-L-tyrosine in peptide libraries supports systematic investigations into the effects of side-chain modifications on biological activity, binding affinity, and selectivity. By substituting canonical tyrosine residues with its dimethylated analogue, scientists can probe the contributions of aromatic interactions, hydrogen bonding capacity, and steric effects within target biomolecular systems. Such studies are instrumental in optimizing lead compounds, elucidating mechanisms of molecular recognition, and guiding the rational design of next-generation peptide-based probes or inhibitors.
Protease Resistance Enhancement: Incorporating 2,6-dimethyl-L-tyrosine into peptide sequences has been shown to increase resistance to enzymatic degradation, particularly by proteases that recognize or cleave at tyrosine-containing motifs. The methyl groups shield the aromatic ring from enzymatic attack, thereby enhancing the metabolic stability of synthetic peptides in biochemical assays or cell-based studies. This feature is highly advantageous in the development of research peptides intended for use in challenging biological environments, where prolonged activity or persistence is required for meaningful data acquisition.
Analytical Method Development: The distinctive structural and chromatographic properties of peptides containing Fmoc-2,6-dimethyl-L-tyrosine make them useful as standards or reference materials in analytical method development. The altered hydrophobicity and retention behavior introduced by the dimethylated residue facilitate the optimization of HPLC or mass spectrometry protocols for peptide analysis. Analytical chemists utilize such modified peptides to validate separation conditions, assess detection sensitivity, and study the impact of side-chain modifications on analytical performance, thereby supporting high-quality data generation in peptide research workflows.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.